We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Genetic Test Unnecessary for Low Doses of Drug, Researchers Say
Genetic Test Unnecessary for Low Doses of Drug, Researchers Say
August 31, 2007
The FDA should change its prescription guidelines for Pfizer’s colorectal cancer drug Camptosar to remove a recommendation for a genetic test before prescribing the drug, University of North Carolina at Chapel Hill researchers said.